Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00017121
What this trial is testing

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Alliance for Clinical Trials in Oncology 40
Early research (Phase 1)Study completedNCT02077114
What this trial is testing

Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma

Who this might be right for
Malignant Melanoma With Metastasis
Herlev Hospital 10
Early research (Phase 1)Ended earlyNCT01557114
What this trial is testing

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Gustave Roussy, Cancer Campus, Grand Paris 19
Early research (Phase 1)Study completedNCT00470015
What this trial is testing

Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT02816021
What this trial is testing

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT05234437
What this trial is testing

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

Who this might be right for
Melanoma
QBiotics Group Limited 1
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00256230
What this trial is testing

Disulfiram in Patients With Metastatic Melanoma

Who this might be right for
Stage IV Melanoma
John P. Fruehauf 7
Testing effectiveness (Phase 2)Ended earlyNCT00849875
What this trial is testing

Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
GlaxoSmithKline 48
Testing effectiveness (Phase 2)UnknownNCT03166397
What this trial is testing

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Who this might be right for
Malignant Melanoma Stage IV
Sheba Medical Center 30
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT00042783
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network
Large-scale testing (Phase 3)Study completedNCT01307397
What this trial is testing

Vemurafenib in Participants With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 3,219
Testing effectiveness (Phase 2)Study completedNCT01884961
What this trial is testing

Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2

Who this might be right for
Metastatic Renal Cell CancerMalignant Melanoma, Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 46
Not applicableStudy completedNCT03199846
What this trial is testing

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

Who this might be right for
Melanoma
Bristol-Myers Squibb 650
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00055562
What this trial is testing

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
Celgene Corporation 274
Testing effectiveness (Phase 2)UnknownNCT02076646
What this trial is testing

A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma Stage IV
Philogen S.p.A. 96
Early research (Phase 1)UnknownNCT05068453
What this trial is testing

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Who this might be right for
Melanoma Stage IV
Peking University Cancer Hospital & Institute 15
Testing effectiveness (Phase 2)WithdrawnNCT02263898
What this trial is testing

Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Jonsson Comprehensive Cancer Center
Next Page